191 related articles for article (PubMed ID: 7745507)
21. Double-blind, randomized trial of one versus three prophylactic doses of synthetic surfactant in 826 neonates weighing 700 to 1100 grams: effects on mortality rate. American Exosurf Neonatal Study Groups I and IIa.
Corbet A; Gerdes J; Long W; Avila E; Puri A; Rosenberg A; Edwards K; Cook L
J Pediatr; 1995 Jun; 126(6):969-78. PubMed ID: 7776110
[TBL] [Abstract][Full Text] [Related]
22. Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome. The American Exosurf Neonatal Study Group I.
Long W; Thompson T; Sundell H; Schumacher R; Volberg F; Guthrie R
J Pediatr; 1991 Apr; 118(4 Pt 1):595-605. PubMed ID: 2007938
[TBL] [Abstract][Full Text] [Related]
23. Reduced mortality in small premature infants treated at birth with a single dose of synthetic surfactant.
Corbet AJ; Long WA; Murphy DJ; Garcia-Prats JA; Lombardy LR; Wold DE
J Paediatr Child Health; 1991 Aug; 27(4):245-9. PubMed ID: 1958425
[TBL] [Abstract][Full Text] [Related]
24. Cost effects of surfactant therapy for neonatal respiratory distress syndrome.
Phibbs CS; Phibbs RH; Wakeley A; Schlueter MA; Sniderman S; Tooley WH
J Pediatr; 1993 Dec; 123(6):953-62. PubMed ID: 8229530
[TBL] [Abstract][Full Text] [Related]
25. Comparative trial of artificial and natural surfactants in the treatment of respiratory distress syndrome of prematurity: experiences in a developing country.
da Costa DE; Pai MG; Al Khusaiby SM
Pediatr Pulmonol; 1999 May; 27(5):312-7. PubMed ID: 10344709
[TBL] [Abstract][Full Text] [Related]
26. A multicenter randomized, masked comparison trial of natural versus synthetic surfactant for the treatment of respiratory distress syndrome.
Hudak ML; Farrell EE; Rosenberg AA; Jung AL; Auten RL; Durand DJ; Horgan MJ; Buckwald S; Belcastro MR; Donohue PK; Carrion V; Maniscalco WW; Balsan MJ; Torres BA; Miller RR; Jansen RD; Graeber JE; Laskay KM; Matteson EJ; Egan EA; Brody AS; Martin DJ; Riddlesberger MM; Montgomery P
J Pediatr; 1996 Mar; 128(3):396-406. PubMed ID: 8774514
[TBL] [Abstract][Full Text] [Related]
27. Elastase activity and surfactant protein concentration in tracheal aspirates from neonates receiving synthetic surfactant.
Gerdes J; Whitsett J; Long W
J Pediatr; 1992 Feb; 120(2 Pt 2):S34-9. PubMed ID: 1735850
[TBL] [Abstract][Full Text] [Related]
28. Outcome at twelve months of adjusted age in very low birth weight infants with lung immaturity: a randomized, placebo-controlled trial of human surfactant.
Vaucher YE; Harker L; Merritt TA; Hallman M; Gist K; Bejar R; Heldt GP; Edwards D; Pohjavuori M
J Pediatr; 1993 Jan; 122(1):126-32. PubMed ID: 8419599
[TBL] [Abstract][Full Text] [Related]
29. Long-term pulmonary consequences of respiratory distress syndrome in preterm infants treated with exogenous surfactant.
Abbasi S; Bhutani VK; Gerdes JS
J Pediatr; 1993 Mar; 122(3):446-52. PubMed ID: 8441104
[TBL] [Abstract][Full Text] [Related]
30. Retinopathy of prematurity in a controlled trial of prophylactic surfactant treatment.
Pennefather PM; Tin W; Clarke MP; Fritz S; Strong NP
Br J Ophthalmol; 1996 May; 80(5):420-4. PubMed ID: 8695563
[TBL] [Abstract][Full Text] [Related]
31. Pulmonary mechanics in premature infants one month after treatment with synthetic surfactant.
Goldman SL; Bosque E; McCann E; Lewis K
J Pediatr; 1992 Feb; 120(2 Pt 2):S25-8. PubMed ID: 1735847
[TBL] [Abstract][Full Text] [Related]
32. Results of laboratory surveillance of very low birth weight infants treated with a synthetic surfactant.
Bose C; Corbet A; Bose G; Prats JG; Russell L; Edwards K
J Pediatr; 1992 Feb; 120(2 Pt 2):S13-7. PubMed ID: 1735845
[TBL] [Abstract][Full Text] [Related]
33. Respiratory distress syndrome in New Zealand: evidence from the OSIRIS trial of exogenous surfactant (Exosurf).
Wach R; Darlow B; Bourchier D; Broadbent R; Knight D; Selby R
N Z Med J; 1994 Jun; 107(980):234-7. PubMed ID: 8208494
[TBL] [Abstract][Full Text] [Related]
34. Retrospective search for bleeding diathesis among premature newborn infants with pulmonary hemorrhage after synthetic surfactant treatment. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
Long W; Corbet A; Allen A; McMillan D; Boros S; Vaughan R; Gerdes J; Houle L; Edwards K; Schiff D
J Pediatr; 1992 Feb; 120(2 Pt 2):S45-8. PubMed ID: 1735852
[TBL] [Abstract][Full Text] [Related]
35. Early or selective surfactant (colfosceril palmitate, Exosurf) for intubated babies at 26 to 29 weeks gestation. A European double-blind trial with sequential analysis. European Exosurf Study Group.
Online J Curr Clin Trials; 1992 Nov; Doc No 28():[3886 words; 47 paragraphs]. PubMed ID: 1343614
[TBL] [Abstract][Full Text] [Related]
36. Synthetic surfactant for rescue treatment of respiratory distress syndrome in premature infants weighing from 700 to 1350 grams: impact on hospital resource use and charges.
Mauskopf JA; Backhouse ME; Jones D; Wold DE; Mammel MC; Mullett M; Guthrie R; Long WA
J Pediatr; 1995 Jan; 126(1):94-101. PubMed ID: 7815233
[TBL] [Abstract][Full Text] [Related]
37. Retinopathy of prematurity and surfactant treatment.
Axer-Siegel R; Snir M; Ma'ayan A; Na'or N; Davidson S; Weinberger D; Yassur Y
J Pediatr Ophthalmol Strabismus; 1996; 33(3):171-4. PubMed ID: 8771520
[TBL] [Abstract][Full Text] [Related]
38. A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome. National Institute of Child Health and Human Development Neonatal Research Network.
Horbar JD; Wright LL; Soll RF; Wright EC; Fanaroff AA; Korones SB; Shankaran S; Oh W; Fletcher BD; Bauer CR
J Pediatr; 1993 Nov; 123(5):757-66. PubMed ID: 8229487
[TBL] [Abstract][Full Text] [Related]
39. Screening for retinopathy of prematurity after surfactant treatment.
Brunner-Di Pietro D; Bossi E; Koerner F
Eur J Pediatr; 1995; 154(9 Suppl 4):S90-4. PubMed ID: 8529721
[TBL] [Abstract][Full Text] [Related]
40. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R;
Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
